Prospector Partners’s NuVasive, Inc. NUVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-85,700
Closed -$4.06M 120
2022
Q4
$4.06M Sell
85,700
-57,475
-40% -$2.33M 0.56% 64
2022
Q3
$6.27M Sell
143,175
-26,500
-16% -$1.28M 0.93% 44
2022
Q2
$8.34M Buy
169,675
+10,725
+7% +$575K 1.21% 33
2022
Q1
$9.01M Sell
158,950
-9,450
-6% -$502K 1.11% 34
2021
Q4
$8.84M Buy
168,400
+15,600
+10% +$848K 1.02% 43
2021
Q3
$9.14M Buy
152,800
+10,200
+7% +$629K 1.17% 36
2021
Q2
$9.66M Sell
142,600
-2,250
-2% -$154K 1.22% 36
2021
Q1
$9.5M Buy
144,850
+68,750
+90% +$4.12M 1.21% 33
2020
Q4
$4.29M Buy
+76,100
New +$3.74M 0.53% 68

Other funds holding NUVA

Prospector Partners's NUVA Position: Q1 2023 in Review

Prospector Partners sold out of NuVasive, Inc. (NUVA) in Q1 2023, closing a stake of 85,700 shares — an estimated $4.06M sold.

Prospector Partners first reported a position in NUVA in Q4 2020 and held it in 9 quarters. The position peaked at $9.66M in Q2 2021. 241 funds tracked by Wall St. Rank hold NUVA as of Q1 2023.

  • Prospector Partners reported no remaining NuVasive, Inc. position as of Q1 2023 after selling out during the quarter.
  • Prospector Partners sold 85,700 NuVasive, Inc. shares in Q1 2023, an estimated $4.06M.
  • Prospector Partners first reported a position in NuVasive, Inc. in Q4 2020 and held it in 9 quarters.
  • Prospector Partners's NuVasive, Inc. position peaked at $9.66M in Q2 2021.
  • 241 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2023.

Based on Prospector Partners's 13F filing for Q1 2023, filed 8 May 2023.